Elanco Animal Health

$13.45
(as of May 30, 9:30 AM EST)

Stock Market Guides is not a financial advisor. Our content is strictly educational and should not be considered financial advice.

Ticker Information for Elanco Animal Health

Stock Price
$13.45
Ticker Symbol
ELAN
Exchange
NYSE

Industry Information for Elanco Animal Health

Sector
Healthcare
Industry
Drug Manufacturers - Specialty & Generic

Company Description for Elanco Animal Health

Country
USA
Full Time Employees
9,000

Elanco Animal Health Incorporated, an animal health company, innovates, develops, manufactures, and markets products for pets and farm animals worldwide. It offers pet health products, such as parasiticides, vaccines, and therapeutics that protect pets from fleas, ticks, and internal parasites under the Seresto, K-9 Advantage, Advantix, and Advocate trademarks; prescription parasiticide products, an over-the-counter treatments for the prevention and elimination of fleas and ticks under the Credelio, Credelio Cat, Credelio Plus, Interceptor Plus, Doncit, Drontal, Drontal Plus, and Trifexis trademarks; vaccines portfolio that provides differentiated prevention coverage for a number of important pet health risks; and therapeutics portfolio for the treatment of pain, otitis, cardiovascular, and dermatology indications, as well as osteoarthritis for dogs and cats under the Galliprant trademark. The company also provides farm animal products that help farmers improve animal health and wellbeing, and raise livestock, such as cattle, swine, and poultry. In addition, it offers medicated feed additives, injectable antibiotics, vaccines, insecticides and enzymes, and others under the Rumensin, Baytril, and Experior trademarks for cattle; and under the Maxiban and Monteban trademarks for the control and prevention of intestinal disease in poultry. Further, the company offers other pet health products for cats and dogs under the Atopica, Milbemax, Onsior, and TruCan trademarks; and other farm animal products for poultry, cattle, and swine under the AviPro, Catosal, Denagard, Hemicell, Pulmotil, and Surmax tradmarks. It sells its products to third-party distributors and independent retailers; and directly to farm animal producers and veterinarians. Elanco Animal Health Incorporated was founded in 1954 and is headquartered in Greenfield, Indiana.

Fundamentals for Elanco Animal Health

Market Capitalization
$6,714,664,448
EBITDA
$862,000,000
Dividends per Share
P/E Ratio
17.92
Forward P/E Ratio
15.9
Earnings per Share
$0.75
Earnings per Share Estimate Next Year
Profit Margin
8.43%
Shares Outstanding
496,646,016
Percent Owned by Insiders
1.03%
Percent Owned by Institutions
101.41%
52-Week High
52-Week Low

Technical Indicators for Elanco Animal Health

50-Day Moving Average
200-Day Moving Average
RSI
70.51
0.54

Analyst Ratings for Elanco Animal Health

Strong Buy
6
Buy
1
Hold
8
Sell
0
Strong Sell
0

News About Elanco Animal Health

May 28, 2025, 11:00 AM EST
The animal health care company Elanco is reaffirming its second quarter and full year guidance. See more.
May 28, 2025, 7:25 AM EST
GREENFIELD, Ind., May 28, 2025 /PRNewswire/ -- Elanco Animal Health Incorporated (NYSE: ELAN) today announced the appointment of Robert VanHimbergen as Executive Vice President and Chief Financial Officer, effective July 7, 2025. See more.
May 26, 2025, 12:39 AM EST
Great things are happening to the stocks in this article. See more.
May 20, 2025, 12:00 AM EST
Elanco has been treading water for the past six months, recording a small loss of 1.3% while holding steady at $13.27. See more.